Find a Doctor
Lynn Stuart Ashby, MD, is a neurologist in the Petznick Stroke Center and a professor of neurology at Barrow Neurological Institute. She is board certified in neurology by the American Board of Psychiatry and Neurology.
Dr. Ashby’s clinical focus is the care of patients with neurovascular disorders, including stroke, transient ischemic attack (TIA), and syncope. She is a member of the American Academy of Neurology, the American Society of Clinical Oncology, and the Society for Neuro-Oncology.
Dr. Ashby earned her master’s and medical degrees from Northwestern University in Chicago. She completed her neurology residency and a fellowship in neuro-oncology at Barrow Neurological Institute.
Dr. Ashby is a sub-investigator for clinical trials being conducted in the Stroke Program. Her research interests are in the medical and interventional treatment of patients with acute stroke.
To request an appointment with Dr. Ashby, please call (602) 406-6262.
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Fellowship, Barrow Neurological Institute, Neuro-Oncology, 1997-1999
- Residency, Barrow Neurological Institute, Neurology, 1994-1997
- Internship, North Shore University Evanston Hospital, Internal Medicine, 1993-1994
- MD, Northwestern University, Feinberg School of Medicine, 1993
- MA, Northwestern University, Art History, 1986
- American Academy of Neurology
- American Society of Clinical Oncology
- Society for Neuro-Oncology
A Randomized Phase II Study of Everolimus in Combination With Chemoradiation in Newly Diagnosed Glioblastoma: Results of NRG Oncology RTOG 0913
Date: 01/2018
Authors: Prakash Chinnaiyan, Minhee Won, Patrick Y. Wen, Amyn M. Rojiani, Maria Werner-Wasik, Helen A. Shih, Lynn S. Ashby, Hsiang Hsuan Michael Yu, Volker W. Stieber, Shawn C. Malone, John B. Fiveash, Nimish A. Mohile, Manmeet S. Ahluwalia, Merideth M. Wendland, Philip J. Stella, Andrew Y. Kee, Minesh P. Mehta
An Extent of Resection Threshold for Seizure Freedom in Patients With Low-Grade Gliomas
Date: 01/2018
Authors: David S. Xu, Al Wala Awad, Chad Mehalechko, Jeffrey R. Wilson, Lynn S. Ashby, Stephen W. Coons, S. W. Coons, Stephen W Coons, Nader Sanai
Intermediate-Risk Meningioma: Initial Outcomes From NRG Oncology RTOG 0539
Date: 01/2018
Authors: Leland Rogers, Peixin Zhang, Michael A. Vogelbaum, Arie Perry, Lynn S. Ashby, Jignesh M. Modi, Anthony M. Alleman, James Galvin, David Brachman, Joseph M. Jenrette, John De Groot, Joseph A. Bovi, Maria Werner-Wasik, Jonathan P.S. Knisely, Minesh P. Mehta
Rindopepimut With Temozolomide for Patients With Newly Diagnosed EGFRVIII-Expressing Glioblastoma (Act IV): A Randomised Double-Blind International Phase 3 Trial
Date: 01/2017
Authors: Michael Weller, Nicholas Butowski, David D. Tran, Lawrence D. Recht, Michael Lim, Hal Hirte, Lynn S. Ashby, Laszlo Mechtler, Samuel A. Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M. O'Rourke, Mark Wong, Mark G. Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, et al.
Atypical Teratoid Rhabdoid Tumor: two Case Reports and an Analysis of Adult Cases With Implications for Pathophysiology and Treatment
Date: 01/2017
Authors: Christopher Dardis, Jared Yeo, Kelly Milton, Lynn S. Ashby, Kris A. Smith, Shwetal Mehta, Emad Youssef, Jenny Eschbacher, J. M. Eschbacher, Jennifer M. Eschbacher, Kathy Tucker, Laughlin Dawes, Neil Lambie, Elizabeth Algar, Elizabeth Hovey
- English
- (602) 406-6262
- Fax: (602) 406-6261
Lynn Stuart Ashby, MD, is a neurologist in the Petznick Stroke Center and a professor of neurology at Barrow Neurological Institute. She is board certified in neurology by the American Board of Psychiatry and Neurology.
Dr. Ashby’s clinical focus is the care of patients with neurovascular disorders, including stroke, transient ischemic attack (TIA), and syncope. She is a member of the American Academy of Neurology, the American Society of Clinical Oncology, and the Society for Neuro-Oncology.
Dr. Ashby earned her master’s and medical degrees from Northwestern University in Chicago. She completed her neurology residency and a fellowship in neuro-oncology at Barrow Neurological Institute.
Dr. Ashby is a sub-investigator for clinical trials being conducted in the Stroke Program. Her research interests are in the medical and interventional treatment of patients with acute stroke.
To request an appointment with Dr. Ashby, please call (602) 406-6262.
- (602) 406-6262
- Fax: (602) 406-6261
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Fellowship, Barrow Neurological Institute, Neuro-Oncology, 1997-1999
- Residency, Barrow Neurological Institute, Neurology, 1994-1997
- Internship, North Shore University Evanston Hospital, Internal Medicine, 1993-1994
- MD, Northwestern University, Feinberg School of Medicine, 1993
- MA, Northwestern University, Art History, 1986
- American Academy of Neurology
- American Society of Clinical Oncology
- Society for Neuro-Oncology
A Randomized Phase II Study of Everolimus in Combination With Chemoradiation in Newly Diagnosed Glioblastoma: Results of NRG Oncology RTOG 0913
Date: 01/2018
Authors: Prakash Chinnaiyan, Minhee Won, Patrick Y. Wen, Amyn M. Rojiani, Maria Werner-Wasik, Helen A. Shih, Lynn S. Ashby, Hsiang Hsuan Michael Yu, Volker W. Stieber, Shawn C. Malone, John B. Fiveash, Nimish A. Mohile, Manmeet S. Ahluwalia, Merideth M. Wendland, Philip J. Stella, Andrew Y. Kee, Minesh P. Mehta
An Extent of Resection Threshold for Seizure Freedom in Patients With Low-Grade Gliomas
Date: 01/2018
Authors: David S. Xu, Al Wala Awad, Chad Mehalechko, Jeffrey R. Wilson, Lynn S. Ashby, Stephen W. Coons, S. W. Coons, Stephen W Coons, Nader Sanai
Intermediate-Risk Meningioma: Initial Outcomes From NRG Oncology RTOG 0539
Date: 01/2018
Authors: Leland Rogers, Peixin Zhang, Michael A. Vogelbaum, Arie Perry, Lynn S. Ashby, Jignesh M. Modi, Anthony M. Alleman, James Galvin, David Brachman, Joseph M. Jenrette, John De Groot, Joseph A. Bovi, Maria Werner-Wasik, Jonathan P.S. Knisely, Minesh P. Mehta
Rindopepimut With Temozolomide for Patients With Newly Diagnosed EGFRVIII-Expressing Glioblastoma (Act IV): A Randomised Double-Blind International Phase 3 Trial
Date: 01/2017
Authors: Michael Weller, Nicholas Butowski, David D. Tran, Lawrence D. Recht, Michael Lim, Hal Hirte, Lynn S. Ashby, Laszlo Mechtler, Samuel A. Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M. O'Rourke, Mark Wong, Mark G. Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, et al.
Atypical Teratoid Rhabdoid Tumor: two Case Reports and an Analysis of Adult Cases With Implications for Pathophysiology and Treatment
Date: 01/2017
Authors: Christopher Dardis, Jared Yeo, Kelly Milton, Lynn S. Ashby, Kris A. Smith, Shwetal Mehta, Emad Youssef, Jenny Eschbacher, J. M. Eschbacher, Jennifer M. Eschbacher, Kathy Tucker, Laughlin Dawes, Neil Lambie, Elizabeth Algar, Elizabeth Hovey
- English